YON E Global B.V.

YON E Global B. V. , based in the Netherlands, is dedicated to developing advanced health monitoring solutions tailored for women, focusing on reproductive health through innovative technology. Founded in 2022 and headquartered in Amsterdam, Netherlands, YON E Global B.

V. specializes in health monitoring devices for women. The company has executed one deal as of November 5, 2025, during which it raised EUR 250,000 in a PRE-SEED funding round led by PMK Ventures, with participation from UniPrisma Venture Studio and individual investors. The founder's specific background is not publicly detailed.

YON E's primary offering is an advanced health monitoring device designed specifically for women, integrating cutting-edge pH-sensing technology and precise temperature monitoring. The device enables real-time tracking of vaginal health indicators, focusing on vaginal pH levels and core temperature fluctuations, which are critical for reproductive health. By providing personalized insights based on these measurements, alongside lifestyle data, the device aims to address significant gaps in women's health monitoring and support fertility. This product is particularly targeted at women seeking to optimize their reproductive health, engage in fertility planning, and enhance overall sexual wellness.

Currently, YON E's device is being developed for markets across Europe, where there is an increasing demand for personalized healthcare solutions. YON E engages in various transactional structures to facilitate its business operations, primarily focusing on direct-to-consumer sales. The company’s revenue streams are derived from the sale of its flagship health monitoring device, supported by an intuitive companion app that provides users with insightful data regarding their reproductive wellness. Subscription models may also be integrated, offering users ongoing access to premium features and personalized health recommendations.

The company is actively seeking strategic partnerships and investors to support the advancement of its medical device through clinical trials and regulatory approval, which may open further revenue opportunities. YON E emphasizes the importance of secure and private management of user data, adhering strictly to European privacy standards as part of its operational framework. In November 2025, YON E Global B. V.

raised EUR 250,000 in pre-seed funding to develop a device that measures vaginal pH and temperature for tracking fertility, infection risk, and reproductive health. The company plans to launch this device within the coming years and aims to expand its market reach across Europe, tapping into the growing demand for women's health technologies. This funding will be instrumental in advancing clinical trials and obtaining necessary regulatory approvals, positioning YON E for broader market entry.